Early Insight

The Assurity MRI pacemaker works together with a wireless remote monitoring system. Remote monitoring capabilities, combined with the audible patient notifier, provide earlier notification of actionable clinical events—allowing you to detect patient status changes sooner.

• The ASSERT clinical trial has shown that subclinical atrial tachyarrhythmias (AT) are associated with a 2.5-fold increased risk of stroke or systemic embolism⁴
• Remote monitoring has been shown to reduce mortality in pacemaker patients⁵
• The Assurity MRI pacemaker can help you identify patients at risk for stroke earlier, with clinically proven AT/AF diagnostic tools⁴
• The Abbott remote follow-up system, Merlin.net™ Patient Care Network (PCN), reduces clinician^6,7 and patient follow-up costs⁷
• Wireless, radio-frequency telemetry offers faster access to clinical data, increasing the possibility for clinical efficiency at implant and follow-up⁸

This device is commercially available for use in select international markets.

References

*For additional information about specific MR Conditional devices and leads, inlcuding scan parameters, warnings, precautions, adverse conditions to MRI scanning and potential adverse events, please refer to the Abbott MRI Ready Systems Manual.

1. Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL & Lamas GA. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation, 2003;107, 2932-2037.
2. Olshansky B, Day J, Lerew D, Brown S, & Stolen K. Eliminating right ventricular pacing may not be best for patients requiring implantable cardioverter–defibrillators. HeartRhythm, 2007;4(7), 886-891.
3. Faulknier B, Richards M. The association of the use of the Ventricular Intrinsic Preference (VIP™) feature with heart failure hospitalization in pacemaker patients. Paper presented at the XV International Symposium on Progress in Clinical Pacing; December 4-7, 2012; Rome, Italy.
4. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, … Hohnloser SH. Subclinical atrial fibrillation and the risk of stroke. New England Journal of Medicine. 2012;366, 120-129.
5. Mittal, S., Piccini, J. P., Snell, J., Prillinger, J. B., Dalal, N., & Varma, N. (2016). Improved survival in patients enrolled promptly into remote monitoring following cardiac implantable electronic device implantation. Journal of Interventional Cardiac Electrophysiology: an international journal of arrhythmias and pacing, 46(2), 129–136. https://doi.org/10.1007/s10840-016-0112-y
6. Lazarus A. Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: Analysis of a worldwide database. Pacing and Clinical Electrophysiology. 2007;30(1), S2-S12.
7. St. Jude Medical. Remote Monitoring. Technical Monograph; GMCRM494. 2009.
8. Crossley GH, Boyle A, Vitense H, Chang Y, Mead RH, & CONNECT Investigators. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: The value of wireless remote monitoring with automatic clinician alerts. Journal of the American College of Cardiology. 2011;57(10), 1181-1189.